Galectin-9 Researchers (IMAGE)
Caption
Drs. Pillai (left) and Abdel-Mohsen (right) and their colleagues used cutting-edge technology to discover that a human, sugar-binding protein attacks latent HIV, and may cure HIV disease in patients undergoing antiretroviral therapy.
Credit
Blood Systems Research Institute
Usage Restrictions
None
License
Licensed content